Medico Remedies Ltd - 540937 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Medico Remedies Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Medico Remedies Ltd - 540937 - Disclosure On E-Voting Results On Resolutions Passed Through Postal Ballot By Medico Remedies Limited
In furtherance to our communication dated 9th October, 2021 in connection with the Postal Ballot conducted by the Company for seeking approval of the Shareholders for matters set out in the Notice of Postal Ballot dated 7th October, 2021 and pursuant to Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the following: 1. Voting Results as required pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 marked as Annexure-I; and 2. Scrutinizers' Report on e-Voting Results on resolutions passed through Postal Ballot marked as Annexure-II The said resolution as set out in Postal Ballot Notice is passed with the requisite majority and is deemed to be passed on the last date of the e-voting, i.e. 9th November, 2021. Medico Remedies Ltd - 540937 - Issuance Of Bonus Shares -Record Date
In compliance with Regulation 42(2) & (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform that the Company has fixed Wednesday, 17th November, 2021 as the record date for the purpose of ascertaining the eligibility of shareholders for issuance of bonus shares in the proportion of 3 (three) fully paid-up equity shares for every 1 (One) existing fully paid-up equity share held subject to the approval of shareholders which is being obtained through Postal Ballot process. Medico Remedies Ltd - 540937 - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Half Year Ended 30Th September, 2021
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve Unaudited Financial Results for the half year ended 30th September, 2021 along with Auditor's limited review report thereon Medico Remedies Ltd - 540937 - Shareholding for the Period Ended September 30, 2021
Medico Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Medico Remedies Ltd - 540937 - Statement Of Investor Complaints For The Quarter Ended September 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- HARESH MEHTADesignation :- Managing Director / Whole Time Director Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper advertisements published in Free Press Journal (English Edition) and in Navshakti (Marathi Edition) on 10th October, 2021 for information on completion of dispatch of Notice of Postal Ballot and details on remote e-voting Medico Remedies Ltd - 540937 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
please find enclosed the Notice of Postal Ballot. The Notice is being sent to all the Members, whose names appear in the Register of Members / list of Beneficial Owners as received from National Securities Depository Limited and Central Depository Services (India) Limited and whose email IDs are registered with the Company / Depositories as on Friday, 1st October, 2021 Medico Remedies Ltd - 540937 - Board approves Bonus Issue
Medico Remedies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 07, 2021. Medico Remedies Ltd - 540937 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today
The Board of Directors at their Meeting held today i.e. 7th October, 2021 has, inter alia considered and approved the following: 1. Increase in Authorized Share Capital of the Company from ? 4,50,00,000 divided into 45,00,000 Equity Shares of ? 10/- each to ? 17,00,00,000 divided into 17,00,000 Equity Shares Equity Shares of ? 10/- each and subsequent alteration to the Memorandum of Association of the Company, 2. Issue of Bonus shares in the ratio of 3:1 (3 (three) fully paid-up equity shares for every 1 (One) existing fully paid-up equity share held by the shareholders), 3. Migration of Listing/Trading of Company''s present listing from SME Platform of BSE Limited to the Main Board of BSE Limited as well as on Main Board of NSE Limited 4. Transactions to be entered into with the related parties of the Company; 5. Approval of Postal Ballot Notice; and 6. Appointment of Scrutiniser for scrutinising the Postal Ballot process in a fair and transparent manner.